These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Author: Xu H, Inagaki Y, Seyama Y, Du G, Wang F, Kokudo N, Tang W.
    Journal: Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869.
    Abstract:
    Aberrant expression of KL-6/MUC1 mucin has been proven to be associated with poorer tumor behavior in many carcinomas. The aim of this study was to evaluate the expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis. The expression of KL-6/MUC1 in 18 cases of pancreatic ductal carcinoma (PDC), 5 cases of intraductal papillary mucinous tumor (IPMT), and 3 cases of islet cell tumor was detected by immunohistochemical staining. To determine the impact of loss of KL-6/MUC1 expression on pancreatic tumor progression, an siRNA targeting MUC1 was synthesized and transfected into Panc-1 cells and Capan-1 cells to knock down KL-6/MUC1 expression. Down-regulation of KL-6/MUC1 expression was detected by reverse transcription-polymerase chain reaction (RT-PCR) and western blotting. E-cadherin and KL-6 mucin co-expression was detected by immunofluorescence. The expression of E-cadherin and E-cadherin/β-catenin comlex was determined by immunoprecipitation. Cell invasive abilities were detected by invasion assay. Positive KL-6/MUC1 staining was observed in all 18 PDC cases (18/18,100.0%) and 1 metastatic IPMT case (1/5, 20.0%). The results suggested that KL-6/MUC1 overexpression may be associated with more aggressive tumor behavior, although the cases of pancreatic cancer tissues in this study are limited. RT-PCR and western blotting showed that both KL-6/MUC1 mRNA and protein can be effectively silenced. Following KL-6/MUC1 knockdown, E-cadherin expression increased. Also, E-cadherin/β-catenin complex expression increased and the invasive ability of the cells decreased. This study indicated that overexpression of KL-6/MUC1 in pancreatic cancer tissues may be associated with metastasis of pancreatic cancer by regulating E-cadherin and E-cadherin/β-catenin complex expression.
    [Abstract] [Full Text] [Related] [New Search]